Skip to main content
. 2021 Mar 12;100(10):e24003. doi: 10.1097/MD.0000000000024003

Table 4.

Univariate analyses for PFS and OS.

PFS OS
HR 95%CI P Value HR 95%CI P Value
RDW (>18.65%) 12.22 2.896–51.59 0.002 7.303 1.998–26.69 .008
Age (≥50 years) 6.103 1.397–26.66 0.011 4.810 1.283–18.03 .011
BAS (≥3%) 0.799 0.116–5.516 0.833 0.628 0.111–3.554 .655
EOS (≥5) 0.294 .584
Hb (<10/L) 1.729 0.410–7.285 0.672 0.683 0.193–2.413 .354
Marrow Blast (>0%) 0.208 1.551 0.269–8.928 .673
Blast (>0%) 1.781 0.422–7.520 0.432 1.696 1.470–6.117 .398
Spleen size (>0cm) 1.336 0.202–8.834 0.785 1.635 0.239–9.115 .637
Sokal socre (intermediate and high risk) 7.605 1.900–30.44 0.025 4.302 1.244–14.87 .044
Hasford socre (intermediate and high risk) 4.587 1.112–18.93 0.040 3.433 0.971–12.14 .056
EUTOS socre (high risk) 2.101 0.123–35.90 0.477 1.669 0.129–21.63 .623
ELTS socre (high risk) 21.23 2.097–215.0 0.010 5.592 1.750–41.70 .002
NO EMR-3M 5.251 2.355–29.74 0.009 3.473 1.898–33.36 .026
NO CCyR-6M 1.875 1.278–20.31 0.037 2.318 2.220–7.911 .049
NO MMR-12M 1.139 1.010–16.96 0.044 6.509 2.294–7.749 .022